William J. Aronson

18.9k total citations · 2 hit papers
310 papers, 12.1k citations indexed

About

William J. Aronson is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, William J. Aronson has authored 310 papers receiving a total of 12.1k indexed citations (citations by other indexed papers that have themselves been cited), including 220 papers in Pulmonary and Respiratory Medicine, 64 papers in Cancer Research and 60 papers in Oncology. Recurrent topics in William J. Aronson's work include Prostate Cancer Treatment and Research (188 papers), Prostate Cancer Diagnosis and Treatment (186 papers) and Cancer, Lipids, and Metabolism (55 papers). William J. Aronson is often cited by papers focused on Prostate Cancer Treatment and Research (188 papers), Prostate Cancer Diagnosis and Treatment (186 papers) and Cancer, Lipids, and Metabolism (55 papers). William J. Aronson collaborates with scholars based in United States, Canada and United Kingdom. William J. Aronson's co-authors include Stephen J. Freedland, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Joseph C. Presti, Frederick J. Dorey, R. James Barnard, Louis J. Ignarro, Jacob Rajfer and Margaret A. Bush and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

William J. Aronson

299 papers receiving 11.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitric Oxide as a Mediator of Relaxation of the Corpus Cavernosum in Response to Nonadrenergic, Noncholinergic Neurotransmission

1992 799 citations William J. Aronson et al. profile →
Follow-up of Prostatectomy versus Observation for Early Prostate Cancer

2017 370 citations William J. Aronson et al. profile →

Peers

Countries citing papers authored by William J. Aronson

Since Specialization

Citations

This map shows the geographic impact of William J. Aronson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Aronson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Aronson more than expected).

Fields of papers citing papers by William J. Aronson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Aronson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Aronson. The network helps show where William J. Aronson may publish in the future.

Co-authorship network of co-authors of William J. Aronson

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Aronson. A scholar is included among the top collaborators of William J. Aronson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Aronson. William J. Aronson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PD48-05 USE OF BLUE LIGHT CYSTOSCOPY AMONG NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS AND OUTCOMES IN AN EQUAL ACCESS SETTING: A PROPENSITY SCORED MATCHED ANALYSIS 2024 ·The Journal of Urology ·(unknown), Ali A. Nasrallah, Lin Gu, (unknown), (unknown), Amanda M. De Hoedt, Chad M. McKee, William J. Aronson, Stephen J. Freedland, Stephen B. Williams	0
2	High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate Cancer on Active Surveillance: The CAPFISH-3 Randomized Clinical Trial 2024 ·Journal of Clinical Oncology ·William J. Aronson, Tristan Grogan, (unknown), Patricia Jardack, (unknown), Claudia Perez, David Elashoff, Jonathan Said, Pinchas Cohen, Leonard S. Marks, Susanne M. Henning	7
3	Diabetes and Prostate Cancer Outcomes in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Results from the SEARCH Cohort 2023 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), (unknown), Amanda M. De Hoedt, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Zachary Klaassen, Martha K. Terris, (unknown), Stephen J. Freedland, Ilona Csizmadi	0
4	The Impact of Blue Light Cystoscopy Use Among Nonmuscle Invasive Bladder Cancer Patients in an Equal Access Setting: Implications on Recurrence and Time to Recurrence 2023 ·Clinical Genitourinary Cancer ·(unknown), Lin Gu, (unknown), (unknown), Amanda M. De Hoedt, Chad M. McKee, William J. Aronson, Stephen J. Freedland, Stephen B. Williams	3
5	A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort 2023 ·Cancer Medicine ·(unknown), Taofik Oyekunle, Zachary Klaassen, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Stephen J. Freedland	1
6	Is time to castration resistant prostate cancer a potential intermediate end-point for time to metastasis among men initiating androgen deprivation therapy for non-metastatic prostate cancer with rapid PSA doubling time (<9 months)? 2022 ·Prostate Cancer and Prostatic Diseases ·Zachary Klaassen, Lauren E. Howard, Christopher J.D. Wallis, Jessica L. Janes, Amanda M. De Hoedt, William J. Aronson, Thomas J. Polascik, (unknown), Christopher J. Kane, Matthew R. Cooperberg, Martha K. Terris, Yuan Wu, Stephen J. Freedland	1
7	Radium-223 Utilization Patterns and Outcomes in Clinical Practice 2022 ·Urology Practice ·(unknown), (unknown), Shannon Stock, Lauren E. Howard, Amanda M. De Hoedt, Martha K. Terris, Christopher L. Amling, Christopher J. Kane, Matthew R. Cooperberg, William J. Aronson, Zachary Klaassen, Thomas J. Polascik, Adriana C. Vidal, Stephen J. Freedland	1
8	Primary Neurofibroma of the Lung1 2019 ·American Review of Tuberculosis ·Eli H. Rubin, William J. Aronson	0
9	Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Emma H. Allott, Lauren E. Howard, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Matthew R. Cooperberg, Stephen J. Freedland	14
10	Predictors of Time to Metastasis in Castration-resistant Prostate Cancer 2016 ·Urology ·Daniel M. Moreira, Lauren E. Howard, (unknown), Hiruni S. Amarasekara, (unknown), (unknown), (unknown), William J. Aronson, Christopher J. Kane, Martha K. Terris, Christopher L. Amling, Matthew R. Cooperberg, (unknown), Stephen J. Freedland	56
11	Is computed tomography a necessary part of a metastatic evaluation for castration‐resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database 2015 ·Cancer ·(unknown), Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Edwin M. Posadas, Stephen J. Freedland	6
12	Serum Lipid Profile and Risk of Prostate Cancer Recurrence: Results from the SEARCH Database 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Emma H. Allott, Lauren E. Howard, Matthew R. Cooperberg, Christopher J. Kane, William J. Aronson, Martha K. Terris, Christopher L. Amling, Stephen J. Freedland	119
13	Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the S hared E qual A ccess R egional C ancer H ospital ( SEARCH ) database 2014 ·British Journal of Urology ·Emma H. Allott, Lauren E. Howard, Matthew R. Cooperberg, Christopher J. Kane, William J. Aronson, Martha K. Terris, Christopher L. Amling, Stephen J. Freedland	40
14	Phase II Prospective Randomized Trial of a Low-Fat Diet with Fish Oil Supplementation in Men Undergoing Radical Prostatectomy 2011 ·Cancer Prevention Research ·William J. Aronson, Naoko Kobayashi, R. James Barnard, Susanne M. Henning, Min Huang, Patricia Jardack, Bing-Rong Liu, Ashley Gray, Junxiang Wan, Ramdev Konijeti, Stephen J. Freedland, Brandon Castor, David Heber, David Elashoff, Jonathan Said, Pinchas Cohen, Colette Galet	61
15	Effect of Low-Fat Diet on Development of Prostate Cancer and Akt Phosphorylation in the Hi-Myc Transgenic Mouse Model 2008 ·Cancer Research ·Naoko Kobayashi, R. James Barnard, Jonathan Said, (unknown), (unknown), (unknown), Ngan Doan, Dorina Gui, David Elashoff, Pinchas Cohen, William J. Aronson	64
16	Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo 2008 ·International Journal of Oncology ·Maryam Sartippour, Navindra P. Seeram, Jian Yu Rao, Aune Moro, Diane Harris, Susanne M. Henning, (unknown), Matthew B. Rettig, William J. Aronson, Allan J. Pantuck, David Heber	94
17	Effect of Altering Dietary ω-6/ω-3 Fatty Acid Ratios on Prostate Cancer Membrane Composition, Cyclooxygenase-2, and Prostaglandin E2 2006 ·Clinical Cancer Research ·Naoko Kobayashi, R. James Barnard, Susanne M. Henning, David Elashoff, Srinivasa T. Reddy, Pinchas Cohen, Pak Shan Leung, (unknown), Stephen J. Freedland, Jonathan Said, Dorina Gui, Navindra P. Seeram, Laura M. Popoviciu, Dilprit Bagga, David Heber, John A. Glaspy, William J. Aronson	131
18	Tea Polyphenols and Theaflavins Are Present in Prostate Tissue of Humans and Mice after Green and Black Tea Consumption 2006 ·Journal of Nutrition ·Susanne M. Henning, William J. Aronson, Yantao Niu, Francisco Conde, (unknown), Navindra P. Seeram, Ru‐Po Lee, Jinxiu Lu, Diane M. Harris, Aune Moro, (unknown), (unknown), R. James Barnard, (unknown), GEORGE S. CSATHY, Vay Liang W. Go, Hong Wang, David Heber	122
19	Predicting biochemical recurrence after radical prostatectomy for patients with organ-confined disease using p27 expression 2003 ·Urology ·Stephen J. Freedland, (unknown), (unknown), Yahya Elshimali, GEORGE S. CSATHY, David Elashoff, Robert E. Reiter, William J. Aronson	17
20	Risk factors for male osteoporosis 2003 ·Urologic Oncology Seminars and Original Investigations ·Francisco Conde, William J. Aronson	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact